Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- Citation:
- JAMA vol 302 (13) 1429-1436
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA 15083, CA 90628, CA-25224, CA116201, L30 CA110870, P30 CA015083, P50 CA116201, U-01 GM61388, U01 GM061388, U10 CA025224
- Corr. Author:
- Authors:
- Werner Schroth Matthew P. Goetz Ute Hamann Peter A. Fasching Marcus Schmidt Stefan Winter Peter Fritz Wolfgang Simon Vera J. Suman Matthew M. Ames Stephanie L. Safgren Mary J. Kuffel Hans Ulrich Ulmer Julia Boländer Reiner Strick Matthias W. Beckmann Heinz Koelbl Richard M. Weinshilboum James N. Ingle Michel Eichelbaum Matthias Schwab Hiltrud Brauch
- Networks:
- Study
- NCCTG-N89-30-52
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Article